Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,558 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systemic inflammation and risk of multiple sclerosis - A presymptomatic case-control study.
Grut V, Biström M, Salzer J, Stridh P, Lindam A, Alonso-Magdalena L, Andersen O, Jons D, Gunnarsson M, Vrethem M, Hultdin J, Sundström P. Grut V, et al. Among authors: andersen o. Mult Scler J Exp Transl Clin. 2022 Nov 22;8(4):20552173221139768. doi: 10.1177/20552173221139768. eCollection 2022 Oct-Dec. Mult Scler J Exp Transl Clin. 2022. PMID: 36440320 Free PMC article.
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
Mattsson N, Axelsson M, Haghighi S, Malmeström C, Wu G, Anckarsäter R, Sankaranarayanan S, Andreasson U, Fredrikson S, Gundersen A, Johnsen L, Fladby T, Tarkowski A, Trysberg E, Wallin A, Anckarsäter H, Lycke J, Andersen O, Simon AJ, Blennow K, Zetterberg H. Mattsson N, et al. Among authors: andersen o. Mult Scler. 2009 Apr;15(4):448-54. doi: 10.1177/1352458508100031. Epub 2009 Jan 19. Mult Scler. 2009. PMID: 19153172
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.
Tedeholm H, Lycke J, Skoog B, Lisovskaja V, Hillert J, Dahle C, Fagius J, Fredrikson S, Landtblom AM, Malmeström C, Martin C, Piehl F, Runmarker B, Stawiarz L, Vrethem M, Nerman O, Andersen O. Tedeholm H, et al. Among authors: andersen o. Mult Scler. 2013 May;19(6):765-74. doi: 10.1177/1352458512463764. Epub 2012 Nov 1. Mult Scler. 2013. PMID: 23124789 Free PMC article.
Early hematopoiesis in multiple sclerosis patients.
Jons D, Kneider M, Fogelstrand L, Jeppsson A, Jacobsson S, Andersen O. Jons D, et al. Among authors: andersen o. J Neuroimmunol. 2016 Oct 15;299:158-163. doi: 10.1016/j.jneuroim.2016.09.004. Epub 2016 Sep 13. J Neuroimmunol. 2016. PMID: 27725115
High serum concentration of vitamin D may protect against multiple sclerosis.
Biström M, Alonso-Magdalena L, Andersen O, Jons D, Gunnarsson M, Vrethem M, Hultdin J, Sundström P. Biström M, et al. Among authors: andersen o. Mult Scler J Exp Transl Clin. 2019 Dec 6;5(4):2055217319892291. doi: 10.1177/2055217319892291. eCollection 2019 Oct-Dec. Mult Scler J Exp Transl Clin. 2019. PMID: 31839980 Free PMC article.
Leptin levels are associated with multiple sclerosis risk.
Biström M, Hultdin J, Andersen O, Alonso-Magdalena L, Jons D, Gunnarsson M, Vrethem M, Sundström P. Biström M, et al. Among authors: andersen o. Mult Scler. 2021 Jan;27(1):19-27. doi: 10.1177/1352458520905033. Epub 2020 Feb 7. Mult Scler. 2021. PMID: 32028836 Free article.
1,558 results